Spots Global Cancer Trial Database for orteronel
Every month we try and update this database with for orteronel cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents | NCT02053311 | Prostate Cancer | Orteronel Placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT01866423 | Adenocarcinoma ... Hormone-resista... Recurrent Prost... Stage IV Prosta... | orteronel laboratory biom... | 18 Years - | University of Southern California | |
| Orteronel as Monotherapy in Patients With Metastatic Breast Cancer (MBC) That Expresses the Androgen Receptor (AR) | NCT01990209 | Metastatic Brea... | Orteronel | 18 Years - | SCRI Development Innovations, LLC | |
| Phase Ib/II Study Evaluating Orteronel (Without Prednisone) Combined With Itraconazole In Men With Castration-Resistant Prostate Cancer (CRPC) | NCT02054793 | Prostate Cancer Castration-resi... | Itraconazole Orteronel | 18 Years - | Johns Hopkins University | |
| Study Comparing Orteronel Plus Prednisone in Participants With Metastatic Castration-Resistant Prostate Cancer. | NCT01193257 | Prostate Cancer | Orteronel Prednisone Orteronel Place... | 18 Years - | Takeda | |
| TAK-700 in Castration Resistant Prostate Cancer | NCT01658527 | Prostate Cancer | Orteronel Bicalutamide | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| TAK-700 in Castration Resistant Prostate Cancer | NCT01658527 | Prostate Cancer | Orteronel Bicalutamide | 18 Years - | European Organisation for Research and Treatment of Cancer - EORTC | |
| Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer | NCT01193244 | Prostate Cancer | Orteronel Placebo Prednisone | 18 Years - | Takeda | |
| Orteronel Maintenance Therapy in Patients With mCRPC Previously Treated With Novel Hormonal Agents | NCT02053311 | Prostate Cancer | Orteronel Placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Orteronel Maintenance Therapy in Patients With Metastatic Castration Resistant Prostate Cancer and Non-progressive Disease After First-line Docetaxel Therapy | NCT01707966 | Prostate Cancer | Orteronel Placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Orteronel in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer | NCT01866423 | Adenocarcinoma ... Hormone-resista... Recurrent Prost... Stage IV Prosta... | orteronel laboratory biom... | 18 Years - | University of Southern California | |
| Study Comparing Orteronel Plus Prednisone in Participants With Chemotherapy-Naive Metastatic Castration-Resistant Prostate Cancer | NCT01193244 | Prostate Cancer | Orteronel Placebo Prednisone | 18 Years - | Takeda |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
